These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1362298

  • 1. [Studies of cerebrospinal fluid diagnosis in Alzheimer's disease: a review of the literature and of current developments].
    van Gool WA, Bolhuis PA.
    Tijdschr Gerontol Geriatr; 1992 Dec; 23(6):212-6. PubMed ID: 1362298
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid markers of Alzheimer's disease.
    van Gool WA, Bolhuis PA.
    J Am Geriatr Soc; 1991 Oct; 39(10):1025-39. PubMed ID: 1918775
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers.
    Silverberg GD, Mayo M, Saul T, Carvalho J, McGuire D.
    Expert Rev Neurother; 2004 Jan; 4(1):97-107. PubMed ID: 15853620
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's disease.
    Galasko D.
    J Neural Transm Suppl; 1998 Jan; 53():209-21. PubMed ID: 9700659
    [Abstract] [Full Text] [Related]

  • 14. Neurotransmitters and neuropeptides in Alzheimer's disease.
    McDonald WM, Nemeroff CB.
    Psychiatr Clin North Am; 1991 Jun; 14(2):421-42. PubMed ID: 1676509
    [Abstract] [Full Text] [Related]

  • 15. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
    MacDonald AB.
    Med Hypotheses; 2007 Jun; 68(4):822-5. PubMed ID: 17055667
    [Abstract] [Full Text] [Related]

  • 16. Review on metal speciation analysis in cerebrospinal fluid-current methods and results: a review.
    Michalke B, Nischwitz V.
    Anal Chim Acta; 2010 Dec 03; 682(1-2):23-36. PubMed ID: 21056712
    [Abstract] [Full Text] [Related]

  • 17. Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms.
    Nilselid AM, Davidsson P, Nägga K, Andreasen N, Fredman P, Blennow K.
    Neurochem Int; 2006 Jun 03; 48(8):718-28. PubMed ID: 16490286
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Diagnosis of Alzheimer's disease].
    Delacourte A.
    Ann Biol Clin (Paris); 1998 Jun 03; 56(2):133-42. PubMed ID: 9754238
    [Abstract] [Full Text] [Related]

  • 20. Is pigment epithelium-derived factor level in cerebrospinal fluid a promising biomarker for early diagnosis of Alzheimer's disease?
    Yamagishi S, Inagaki Y, Takeuchi M, Sasaki N.
    Med Hypotheses; 2004 Jun 03; 63(1):115-7. PubMed ID: 15193361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.